DR. T. NARENDER
Scientist-E-I
Medicinal and Process Chemistry Division
Central Drug Research Institute
Lucknow-226 001 (U.P), India
Educational Qualifications M Sc., B Ed., Ph.D.
Phone No. +91-0522-2612411-18 Ext: 4440
Fax No. +91-0522-2623405, 2623938
E-Mail

t_narendra@cdri.res.in

Date of Birth 20.06.1969
 
RESEARCH EXPERIENCE
 
Natural Products Chemistry (Medicinal plants, Marine organisms, Marine bacteria and fungus)
 
POST-DOCTORAL EXPERIENCE
 
One year at Scripps Institution of Oceanography, University of California, San Diego, USA from March 2007 to April 2008 with Prof. William Fenical on Marine microorganisms (bacteria and fungus)
 
AWARDS
 
DST, New Delhi awarded BOYSCAST fellowship
CDRI Incentive Award in the years 2008
 
RESEARCH GROUP

1. Dr. Shweta (Currently Post-Doc at Turku University, Finland)
2. Dr. Tanvir Khaliq (Currently Post-Doc at Washington University, USA)
3. Mr. Papi Reddy (Currently Post-Doc at Portland State University, USA)
4. Mr. Satinath Sarkar (JRF)
5. Mr. Gaurav Madhur (JRF)
6. Mr. Sriniwas Tiwari (JRF)
7. Mr. Venkateswarlu (JRF)
8. Mr. Vinay Kumar Singh (JRF)
9. Mr. K. Rajendar (JRF)
10. Mr. Prasanta Ghosal (JRF)
11. Mr. J.P.Chaturvedi (TO)

 
 
CURRENT AREAS OF INTEREST
Written records of the use of natural products as medicinal agents date back thousands of years. The oldest records come from Mesopotamia and date from about 2600 BC, however, it was not until the early 1800’s that the active principles from plants were isolated. Natural products isolated from plants, animals and microorganisms have made an important impact on curing the dreadful diseases for example taxol, vinca alkaloids, podophyllotoxins camptothecin derivatives for cancer treatment; pencillins, streptomycins, tetracyclines as antibiotics; quinine and artemisinin for malaria treatment.

Our major research activities are identification of biologically active lead molecules through activity guided fraction and isolation work on the medicinal plants, marine organisms and microorganisms for metabolic diseases (hyperglycemia, dyslipidemia), parasitic diseases (leishmania and malaria), cancer, HIV etc., and chemical transformation of natural products of biological importance to improve their potency. We synthesize these biologically active lead molecules and their analogues in our laboratory. During this process we develop new methods for the synthesis of bioactive compounds and exploit some reagents to perform selective functions in the synthesis of biologically active compounds. We also isolate new chemical constituents from plants, marine organisms, microorganisms and elucidate their complex chemical structures by using modern 2D-NMR techniques such as COSY, HSQC, HMBC, NOESY, ROESY etc.

Antihyperglycemic and Antidyslipidemic Agents
Obesity, insulin resistance (Diabetes) and dyslipidemia are generally found as a part of a complex mixture of metabolic abnormalities collectively known as the metabolic syndrome. As a part of our natural products program we identified few lead molecules from Indian medicinal plants for metabolic disorder diseases for example Aegeline, an alkaloidal amide isolated from the leaves of Aegle marmelos (bael), exhibits the potent lipid lowering activity and mild antihyperglycemic activity; 4-hydroxyisoleucine an unusual amino acid from Trigonella foenum graecum (methi seeds) exhibits dual activity (antidyslipidemic and antihyperglycemic). terpenoid derivatives (a-amyrin and lupeol) exhibits antihyperglycemic activity. Modified furanoflavonoids (pseudosemiglabrin and semiglabrin) isolated from Indigofera tinctoria showed good lipid lowering activity.


 
   
 

Antihyperglycemic and Antidyslipidemic Agents
The protozoan parasite Leishmania cause a broad spectrum of diseases ranging from cutaneous healing skin lesions caused by L. major to a fatal visceral form called kala azar caused by L. donovani. We identified an orally active antileishmnaial agent i. e., Peganine from the seeds of Peganum harmala. It induces apoptosis- like cell death in L. donovani. The binding interactions between peganine and DNA topoisomerase I in molecular modeling studies (docking) and experimental studies suggested that the apoptosis like cell death appears to be due to L. donovani’s topoisomerase I inhibition. We also obtained few natural chromenodihydrochalcones, which exhibits antileishmanial activity in in-vitro studies. We synthesized several analogues of these chalcones and studied their in-vitro and in-vivo antileishmanial activity.

 
       

Anticancer taxanes
In continuation of our drug discovery program on anticancer agents we isolated 2-deacetoxytaxinine J (2-DAT-J) in reasonably good yield (0.1%) from the Indian T. baccata (ssp. wallichiana). It has effects on the Ca2+ induced microtubule depolymerization. 2-DAT-J is a powerful inhibitor of P-glycoprotein (P-gp) activity, acting as efficient reversing agent in multi-drug resistant (MDR) cancer cells.

           

Anti HIV coumarins
Recently we initiated research work on the calanolide class of compounds, which are known for their HIV reverse transcriptase inhibiting activity. We isolated few coumarins from Calophyllum inophyllum to develop anti HIV and anti TB compounds.

           

We also isolate novel compounds from natural sources and identify their complex chemical structures using modern NMR tools. For example we isolated few novel limonoids from
Xylocarpus molluccensis,a triterpene from Peganum harmala and bisuracil derivative from marine sea hare (Dolabella auricularia).


 
   
 
 
 
SELECTED PUBLICATIONS
 
T.Narender, K.P.Reddy, and G. Madhur. Synthesis of (E)-Stilbenes and (E,E)-1,4-Diphenylbuta-1,3-diene promoted by Borontrifluoride-etherate complex. Synthesis 2009, 22, 3791-3796.
T. Narender, T. Khaliq, A.B. Singh, M.D. Joshi, P. Mishra, J.P. Chaturvedi, A.K. Srivastava, R. Maurya, S.C. Agarwal. Synthesis of a-amyrin derivatives and their in vivo antihyperglycemic activity. European Journal of Medicinal Chemistry 2009, 44, 1215-1222.
Tanvir Khaliq, Pragya Misra, Swati Gupta, K. Papi Reddy, Ruchir Kant, P. R. Maulik, Anuradha Dube and T. Narender. Peganine hydrochloride dehydrate an orally active antileishmanial agent. Bioorg. Med. Chem. Lett. 2009, 19, 2585-2586
K. Papi Reddy, Hemant K Bid, V. Lakshma Nayak, Preeti Choudhury, J. P. Chaturvedi, K. R. Arya, Rituraj Konwar, T. Narender In vitro and in vivo anticancer activity of 2-deacetoxytaxinine J and synthesis of novel taxoids and their in vitro anticancer activity. Europ. J. Med.Chem. 2009, 44, 3947-3953.
K. Papi Reddy, A. B. Singh, A. Puri, A. K. Srivastava and T. Narender Synthesis of novel Triterpenoid (Lupeol) derivatives and their in vivo Antihyperglycemic and Antidyslipidemic activity Bioorg. and Med. Chem. Lett. 2009, 19, 4463-4466.
T. Narender, K. Papi Reddy and Shweta.BF3.OEt2 mediated One-pot Synthesis of Acetylchromans from Polyhydroxyacetophenones and Isoprene/Allylalcohol. Synthetic Communications. 2009, 39, 384-394.
T. Narender, K. Papi Reddy and G. Madhur. NaOAc mediated selective deprotection of aromatic acetates and its application in the synthesis of natural products. Synthetic Communications 2009, 39, 1949-1956.
Misra Pragya, Khaliq Tanvir, Dixit Anshuman, Sengupta Souvik, Samant Mukesh, Kumari Shraddha, Kumar Awanish, Kushawaha Pramod, Majumder Hemanta, Saxena Anil, Narender T and Dube Anuradha. Antileishmanial activity mediated by apoptosis and structure based target study of Peganine hydrochloride dihydrate: An approach for rational drug designing Journal of Antimicrobial Chemotherapy, 2008, 62, 998-1002.
T. Narender, * T. Khaliq and Shweta 13C-NMR Spectroscopy of B,D-Ring Seco Limonoids of Meliaceae family. Natural Product Research. 2008, 22, 763,-800.
T. Narender,* K. Papi Reddy, Brijesh Kumar. BF3.OEt2 mediated regioselective deacetylation of polyacetoxyacetophenones and its application in the synthesis of natural products. Tetrahedron Letters 2008, 49, 4409–4415.
A. Sankaranarayanan, T. Narender, S.Kumar and M. Dikshit. Allium sativum constituents: effect on free radical generation from rat neutrophils. Cellular and Molecular Biology 2007, 53, 63-67.
T. Narender* and K. Papi Reddy. A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate. Tetrahedron Letters 2007, 48, 3177–3180. (This article ranked 3 out of 25 hottest articles listed by Elsevier publications during the period of second quarter of the year 2007, April-June)
T. Narender* and K. Papi Reddy. BF3.OEt2 mediated biogenetic type synthesis of chromanochalcones from prenylated chalcones via a regioselective cyclization reaction. Tetrahedron Letters 2007, 48, 7628–7632.
T. Narender,* K. Papi Reddy, Shweta, Kumkum Srivastava, D. K. Mishra and S. K. Puri. Total Synthesis of Munchiwarin, a Triprenylated Chalcone from Crotalaria medicagenia. Organic letters 2007, 9, 5369-5372.
K.V.Shashidhara,* N. Rosiah, T. Narender*. Highly Efficient and Regioselective Synthesis of 7-Hydroxy-4-methyl-2-oxo-2H-benzo[h]chromene-8,10 dicarbaldehyde’s and 1-Hydroxynaphthalene-2,4-dicarbaldehyde’s Keto-Enamine Schiff bases. Tetrahedron Letters. 2007, 48, 1699-1702.
T. Narender* and T. Khaliq. A New Triterpenoid from Peganum harmala. Natural Products Communications 2007, 2, 1079-1081.
T. Narender,* T. Khaliq, Shweta, K.Papi Reddy, R.K. Sharma Occurrence, Biosynthesis, Biological activity and NMR Spectroscopy of D and B, D Ring Seco-limonoids of Meliaceae Family. Natural Products Communication 2007, 2, 203-221.
T. Narender,* Shweta, P. Tiwari, K. Papi Reddy, T. Khaliq, A. K. Srivastava, S. C. Agarwal, and K. Raj Antihyperglycemic agent and Antidyslipidemic agent from Aegle marmelos Bio-org. Med. Chem. Letters 2007, 17, 1808-1811.
T. Narender,* T. Khaliq and M.N.Srivastava. 2007 Naturally occurring Uracil dimer from the Marine sea hare Dolabella auricularia Natural Products Communications 2, 71-73.
Anju Puri, Tanvir Khaliq, Rashmi Saxena, Geetica Bhatia and Ramesh Chander Tadigoppula Narender*, 2007. Antidyslipidemic activity of Indigofera tinctoria. J. Herbal Pharmacotherapy,1, 57-64.
Xyloccensin X and Y, Two New Limonoids from Xylocarpus molluccensis: NMR Investigation in Mixture. Abhijeet Deb Roya, Rajesh Kumar, Poonam Gupta, Tanvir Khaliq, T. Narender, Vijailakshmi and Raja Roy 2006. Magnetic Resonance in Chemistry, 44, 1054-1057.
Antidyslipidemic activity of Furano Flavonoids isolated from Indigofera tinctoria. T. Narender, T. Khaliq, A. Puri, R. Chander, 2006. Bio-org. Med. Chem. Lett., 16, 3422-3414.
4-Hydorxyisoleucine an unusual Amino acid as Antidyslipidemic and Antihyperglycemic agent. T. Narender, Anju Puri, Shweta, Tanvir Khaliq, Rashmi Saxena, Geetica Bhatia and Ramesh Chander, 2006. Bio-org. Med. Chem. Lett. 16, 293-296.
Synthesis of Chromenochalcones and Evaluation of their in-vitro Antileishmanial activity. T.Narender, K. Tanvir,. Shweta., Nishi. N.Goel, S. Gupta, 2005. Bio-org. Med. Chem. 13, 6543-6550
Prenylated Chalcones isolated from Crotalaria genus inhibits in-vitro growth of the human malaria parasite Plasmodium falciparum T. Narender, Shweta, K.Tanvir, M.Srinivasa Rao, K.Srivastava and S.K.Puri.2005, Bioorg. Med. Chem. Lett., . 15, 2453-2455
A Convenient and Biogenetic type Synthesis of few naturally occurring Chromenodihydrochalcones and their in-vitro antileishmanial activity T. Narender, Shweta and S.Gupta 2004. Bioorg. Med. Chem. Lett., 14, 3913-3916.
Neoadifoline a New Indole Alkaloid from the Adina cardifolia, B.Balazs, G. Toth, P.S.Rao, T. Narender, N.Subbarao, Gy.Howarth and H.Duddeck., 1999. Magn. Res. Chem., 37, 751-753.
Further dihydro chalcones from the Crotalaria ramosissima, J.K.Kumar, T. Narender, M.S.Rao, P.S.Rao, G.Toth, B.Balazs and H.Duddeck,1999. J. Braz. Chem. Soc., 10, 278-280